Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
To register your interest for these sessions, please email as directed under the specific training.
To register your interest for these sessions, please email as directed under the specific training.
For further information on any of the sessions listed above, please email our CRM Education team.
Meet Cobalt XT ICDs and CRT-Ds
Exclusive ATP algorithm, heart failure risk stratification, tablet-based programming and app-based remote monitoring, extended longevity, and 40 J on all shocks.
SmartShock technology can help steer patients clear of inappropriate and unnecessary shocks.1,2
DISCOVER MOREFind additional feature information along with a variety of educational resources and tools.
Visit Medtronic Academy
Auricchio A, Schloss EJ, Kurita T, Meijer A, Gerritse B, Zweibel S, Al Smadi FM, Leng CT, Sterns LD, on behalf of the PainFree SST Investigators. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm 2015;12:926-936.
Regoli F, Graf D, Schaer B, Duru F, Ammann P, Mangoni di S. Stefano6 L, Naegli B, Burri H, Zbinden R, Krasniqi N, Fromer M and 4P Study Group. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator – results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P). BMC Cardiovascular Disorders (2019) 19:146